| Literature DB >> 28700817 |
Yueqin Zheng1, Bingchen Yu1, Zhen Li2, Zhengnan Yuan1, Chelsea L Organ2, Rishi K Trivedi2, Siming Wang1, David J Lefer2, Binghe Wang1.
Abstract
A strategy to deliver a well-defined persulfide species in a biological medium is described. Under near physiological conditions, the persulfide prodrug can be activated by an esterase to generate a "hydroxymethyl persulfide" intermediate, which rapidly collapses to form a defined persulfide. Such persulfide prodrugs can be used either as chemical tools to study persulfide chemistry and biology or for future development as H2 S-based therapeutic reagents. Using the persulfide prodrugs developed in this study, the reactivity between S-methyl methanethiosulfonate (MMTS) with persulfide was unambiguously demonstrated. Furthermore, a representative prodrug exhibited potent cardioprotective effects in a murine model of myocardial ischemia-reperfusion (MI/R) injury with a bell shape therapeutic profile.Entities:
Keywords: bell shape therapeutic profile; hydrogen sulfide; persulfide; prodrugs
Mesh:
Substances:
Year: 2017 PMID: 28700817 DOI: 10.1002/anie.201704117
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336